KATHERINE HENRY: Open Payments
NPI 1174111314 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 26 payments from 10 companies in 2025. Trend: 2023 $566 · 2024 $803 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $99 |
| Novo Nordisk Inc | 4 | $80 |
| Exact Sciences Corporation | 3 | $60 |
| Amgen Inc. | 3 | $56 |
| ABBVIE INC. | 3 | $47 |
| Abbott Laboratories | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Corcept Therapeutics | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: Dexcom G6 Transmitter, Cologuard Collection Kit, Ozempic, QULIPTA, FREESTYLE LIBRE 3, OTEZLA, KRYSTEXXA, JARDIANCE.
Industry payments across AL — which companies pay providers there.
